The presence of oligoclonal bands (OCBs) of immunoglobulin G (IgG) 
The demonstration of OCBs of IgG in the CSF provides valuable evidence of the occurrence of a humoral immune response. -3 However, from the point of view of clinical diagnosis, OCBs are a non-specific finding: a wide range of pathologies, in particular infection, inflammation and neoplasia, may provoke such an immune response. 3 Sensitive modern immunochemical methods4 demonstrate OCBs of immunoglobulin G in the serum as well as in the CSF in an appreciable proportion of cases: comparison of the response in CSF and serum in a given patient would offer an opportunity to narrow down the differential diagnosis of OCBs if it turned out that distribution of OCBs between CSF and serum had distinct diagnostic implications. In fact, this is the case, and the main aim of this paper is to provide a "user's guide" to the interpretation of the presence of serum oligoclonal bands.
Patients and methods 1) Isoelectric focusing CSF and serum were examined for OCBs of immunoglobulin G by isoelectric focusing, followed by passive protein transfer to a nitrocellulose membrane and immunostaining of the protein attached to the membrane for immunoglobulin G by a double antibody method. This technique has been described fully in a previous paper. 4 In brief, it involves application of a 2-5 microlitres of sample (diluted 1:400 in the case of serum) to an agarose gel containing synthetic ampholytes (molecules bearing variable net charge). Following the application of an electric field across the gel, ampholytes and proteins migrate to a position in the gel determined by their isoelectric point (the pH at which they bear no net charge). This achieves a good separation of IgG clones, as individual clones tend to differ in isoelectric point. The proteins in the gel are then transferred to a nitrocellulose membrane, to which they stick passively, by laying the membrane over the gel and applying a weight. Clones of IgG are visualised by incubation of the membrane with an antibody to human IgG, followed by a second antibody directed against the first and coupled to an enzyme (horseradish peroxidase) which can be visualised chemically. By this method a monoclone of IgG generates several bands: these, however, have a very characteristic appearance, so that there is generally no difficulty in distinguishing bands indicative of a single clone from those indicative of two or more clones. The method is very tolerant of variations in the CSF IgG concentration, and yields satisfactory results over a 50 fold range, from applications of 20 to 1200 ng of IgG.4
2) Classification of isoelectric focusing patterns
An oligoclonal response is defined as the presence of two or more distinct antibody clones. These antibody clones are visible because they stand out against the background of polyclonal antibody as a result of the relatively intense stimulation of a corresponding number of clones of lymphocytes responsible for their production. Three patterns of oligoclonal response in CSF and serum are distinguished: 1) patients with at least two clones in CSF, but none in serum, have an exclusively intrathecal oligoclonal response: we refer to this pattern as "intrathecal-only" (symbolised in the figure by a +); 2) patients with at least two clones which are identical in CSF and serum have evidence of a systemic oligoclonal response. We refer to this pattern as "systemic- Results Table 1 shows the diagnoses of patients with the "systemic-only" and "intrathecal-systemic" responses.
The main findings were: 1) peripheral neuropathies were diagnosed commonly among patients with identical CSF and serum OCBs ("systemic-only" response) but did not occur among patients displaying the "intrathecalsystemic" response (p < 0-0001); 2) similarly, neoplastic disorders were common among patients with identical CSF and serum bands but were rarely diagnosed among patients with the "intrathecal-systemic" response (p < 0 05).
Where the latter response was seen in association with neoplasia a paraneoplastic syndrome or lymphocytic CNS tumour was responsible; 3) multiple sclerosis was the most frequent single cause of the "intrathecal-systemic" response but occurred in only 1 patient with identical OCBs in CSF and serum (p<000001); 4) however, an examination of the results for the entire patient group with serum OCBs, including both patients with the "systemic-only" and with the "intrathecalsystemic" response, revealed that infectious and inflammatory disorders were found among these patients as often as multiple sclerosis.
Discussion
A wide variety of methods have been used to demonstrate immunoglobulin synthesis within the CNS. A qualitative method, isoelectric focusing, is known to give a more sensitive indication of the occurrence of an intrathecal humoral immune response than do quantitative methods:3 the presence of clonal antibodies in the CSF which are absent from the serum provides very strong evidence of an intrathecal immune response. The occurrence of serum OCBs is not widely appreciated, and little information is available on their significance. Identical CSF and serum OCBs provide evidence of systemic immune activation but not of intrathecal synthesis: in this case the presence of OCBs in the CSF is explained by their passive movement from the serum into the CSF across the bloodbrain barrier which offers only a relative obstacle to serum proteins.5 (In theory additional intrathecal synthesis might sometimes be contributing in these cases but quantitative measurements would be necessary to determine this). In patients in whom serum OCBs are accompanied by additional OCBs unique to CSF there is evidence of both systemic and intrathecal synthesis of immunoglobulin.
The proportions of results falling in the various categories we have described are dependent on the nature of the population sampled by our laboratory, and cannot be extrapolated confidently to very different patient populations. However, certain general principles emerge from our findings, and the results reinforce a number of important points about the nature and demonstration of OCBs.
First, from the standpoint of everyday clinical diagnosis, they are a non-specific finding, occurring in infections, in systemic and local inflammatory disorders including multiple sclerosis, in peripheral neuropathies and in neoplasia. Second, it is vital that serum should be examined in parallel with CSF to establish whether CSF OCBs are the result of intrathecal or of systemic synthesis, or of a combination of the two, and thus to narrow down the diagnostic implications of a positive result. This recommendation has been made in the past,' 2 but is often ignored.
Turning to the pathologies which give rise to OCBs, the most frequent single indication for the immunological analysis of CSF is the investigation of suspected multiple sclerosis. Our previous findings, typical of many others,6 have indicated that multiple sclerosis characteristically gives rise to intrathecal OCBs without a detectable serum response. A substantial proportion of patients with multiple sclerosis, however, do display serum bands,7 which are fainter and fewer than their counterparts in CSF: the results reported here suggest that multiple sclerosis is the most common single cause of such a mixed "intrathecal-systemic" response. This is of theoretical interest, as it points to systemic immune activation. We are at present investigating associations between the presence of serum bands in patients with multiple sclerosis and clinical features, for example the question of whether the presence of serum bands might be related to infective triggers of relapse.
Identical OCBs in CSF and serum are very rarely seen in multiple sclerosis of any kind and, like a negative result, should lead to reconsideration of the diagnosis. Failure to compare CSF and serum patterns could be seriously misleading where, for example, the differential diagnosis lies between a myelopathy and a peripheral neuropathy.
Infections can give rise to any of the three patterns of OCBs: however, it was striking from examination of the specific diagnoses among our patients that OCBs identical in CSF and serum tended to result from systemic Peripheral neuropathies accounted for 34% of cases with OCBs identical in CSF and serum in our series. There may be several explanations for the systemic immune response to which this finding bears witness: Guillain-Barre syndrome is often preceded by an infection which might provoke such a response, and OCBs have been reported in this condition in the past;8 neuropathies such as those due to vitamin B12 deficiency in pernicious anaemia, diagnosed in one of the patients in the present series, occur in a context of systemic autoimmunity; the occasional presence of OCBs in inherited and metabolic neuropathies suggests other, less straightforward, processes are at work. Table 2 summarises our experience of the distribution of OCB patterns among the pathological groups. Although it is of theoretical interest that a number of conditions causing intrathecal IgG synthesis also give rise to serum OCBs, the diagnostic implications of the "intathecal-only" and the "intrathecalsystemic" responses are broadly similar; by contrast, the finding of identical CSF and serum OCBs, the "systemic-only" response, raises the possibility of a variety of systemic disorders. The mechanisms giving rise to OCBs are complex, and other groups have, for example, reported an incidence of intrathecal synthesis of oligoclonal Immunoglobulin G in as many as 11% of patients with cerebrovascular diseases. 9 We believe that differences in patient selection and in immunochemical methods, especially in the choice of ampholytes,4 underly the discrepancy between these results and ours.
While we have emphasised that the presence of OCBs is a non-specific and ambiguous finding, this is, in a sense, the source of its value: the presence of OCBs of immunoglobu- 
